Photobiomodulation Therapy in the Prevention and Management of Radiotherapy-induced Vaginal Toxicity
Recruiting
N/A
Interventional Study
Radiotherapy Side Effect
Vaginal Abnormality
No Placebo Group
Every participant receives an active treatment — no one gets a placebo.
At a Glance
- Age
- 18 and older
- Sex
- Female
- Study type
- Interventional
- Purpose
- Prevention
- Participants needed
- 62 (estimated)
- Sponsor
- Jessa Hospital · Other
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
Check Your Eligibility
About This Trial
This study aims to investigate the effectiveness of photobiomodulation therapy (PBMT) in the prevention and management of radiotherapy-induced vaginal toxicity (RIVT). Therefore, we hypothesize that PBMT can reduce the severity of RIVT in gynecological cancer patients, increasing the patient's QoL and sexual functioning.
Trial Locations
Loading…
Loading trial locations…
Eligibility Criteria
Inclusion Criteria:
* Diagnosed with endometrial cancer
* Scheduled for external beam radiotherapy (EBRT), intracavitary brachytherapy (BT), or a combination
* Age ≥ 18 years
* Able to comply to the study protocol
* Able to sign written informed consent
Exclusion Criteria:
* Metastatic disease
* …
Contacts